Clinical Trials Browser

Phase NA × Withdrawn × Pancreatic Ductal Adenocarcinoma × Clear all

NCT01911416 2016-06-09

A Biomarker Study to Identify Predictive Signatures of Response to LDE225 (Hedgehog Inhibitor) In Patients With Resectable Pancreatic Cancer

Phase NA Withdrawn

Gastrointestinal

Pancreatic Ductal Adenocarcinoma